These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1699989)

  • 1. Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria.
    Brunet C; Bédard PM; Hébert J
    J Allergy Clin Immunol; 1990 Nov; 86(5):787-93. PubMed ID: 1699989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticaria.
    Bédard PM; Brunet C; Pelletier G; Hébert J
    J Allergy Clin Immunol; 1986 Dec; 78(6):1121-5. PubMed ID: 2431027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of compound 48/80-induced skin histamine release and leukotriene production in chronic urticaria.
    Brunet C; Bédard PM; Hébert J
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):398-402. PubMed ID: 2459174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D; Rihoux JP
    Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative time course study of the skin response to histamine and the effect of H1 blockers. A 3-week crossover double-blind comparative trial of cetirizine and terfenadine.
    Rihoux JP; Van Neste DJ
    Dermatologica; 1989; 179(3):129-34. PubMed ID: 2574115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
    Okayama Y; Benyon RC; Lowman MA; Church MK
    Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
    Ghys L; Rihoux JP
    J Int Med Res; 1989; 17(1):24-7. PubMed ID: 2565265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine.
    Goetz DW; Jacobson JM; Murnane JE; Reid MJ; Repperger DW; Goodyear C; Martin ME
    J Allergy Clin Immunol; 1989 Sep; 84(3):316-22. PubMed ID: 2570798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission.
    Jacques P; Lavoie A; Bédard PM; Brunet C; Hébert J
    J Allergy Clin Immunol; 1992 Jun; 89(6):1139-43. PubMed ID: 1376735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the central and peripheral effects of cetirizine and terfenadine.
    Pechadre JC; Vernay D; Trolese JF; Bloom M; Dupont P; Rihoux JP
    Eur J Clin Pharmacol; 1988; 35(3):255-9. PubMed ID: 2903059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inhibition of wheal response to histamine by multiple doses of terfenadine.
    Ryan WM
    Ann Allergy; 1989 Dec; 63(6 Pt 2):609-11. PubMed ID: 2574553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.
    Phillips GD; Polosa R; Holgate ST
    Clin Exp Allergy; 1989 Jul; 19(4):405-9. PubMed ID: 2569356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of loratadine and clemastine on histamine release in human skin.
    Hägermark O; Wahlgren CF; Giös I
    Skin Pharmacol; 1992; 5(2):93-8. PubMed ID: 1379054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.
    Togias AG; Proud D; Kagey-Sobotka A; Freidhoff L; Lichtenstein LM; Naclerio RM
    Ann Allergy; 1989 Nov; 63(5):465-9. PubMed ID: 2573301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
    García G; DeMora F; Ferrer L; Puigdemont A
    Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
    dos Santos RV; Magerl M; Mlynek A; Lima HC
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):495-9. PubMed ID: 19558008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.